CuraSen Therapeutics, Inc.
PrivateLast Round
Series B
Aug 20, 2024
Est. Valuation
$123.5M
Total Funding Raised
$84.11M
Company Overview
CuraSen Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small molecule drugs to treat a broad range of psychiatric and neurodegenerative diseases, including Parkinson's and Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CuraSen Therapeutics, Inc. Comparables
Compare CuraSen Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Athira Pharma | 77% | |
| Gain Therapeutics Inc | 73% | |
| AC Immune SA | 73% | |
CuraSen Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 20, 2024 | ||||
| Grant | Oct 9, 2023 | ||||
| Series A Extension | Nov 5, 2021 | ||||
| Series A | Oct 17, 2018 |
CuraSen Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series A |
| New Leaf Venture Partners | Series A |
| A. M. Pappas & Associates | Series A Extension, Series A |
| Tekla Capital Management | Series A |
| Chiesi Ventures | Series A Extension |
| Johnson & Johnson Innovation - JJDC, Inc. | Series A |
| ICG Infra | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2024
$6M round led by ICG Infra.
- Oct 17, 2018
$55M round led by New Leaf Venture Partners.
CuraSen Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CuraSen Therapeutics, Inc.'s valuation, stock price, and market status.